22 juin 2026

Webinaire | Expanding Access to HIV Treatment for Children and Adolescents in Africa

Webinaire | Expanding Access to HIV Treatment for Children and Adolescents in Africa

Webinaire | Expanding Access to HIV Treatment
for Children and Adolescents in Africa

Présentateur

Dr. Chishala Chabala
Pédiatre au CHU de Lusaka
School of Medicine, University of Zambia

Titre

Expanding Access to HIV Treatment for children and adolescents: Progress and Persistent challenges

Regarder le webinaire

Bio

Chishala Chabala est maître de conférences et pédiatre consultant à la School of Medicine de l’Université de Zambie et à l’University Teaching Hospital de Lusaka, en Zambie, où il enseigne, mène des recherches et assure des soins cliniques.
Il dirige un groupe de recherche clinique consacré aux enfants atteints de tuberculose, de VIH et de pneumonie, et a participé en tant qu’investigateur à plusieurs essais cliniques internationaux, notamment auprès d’enfants vivant avec le VIH (essais CHAPAS-3, CHAPAS-4 et Empirical).
Davantage d’information sur Dr Chishala Chabala

Résumé

40 million people were living with HIV, with over two thirds of these residing in Africa, predominantly in Southern Africa. Globally, progress has been made towards universal access to antiretroviral therapy and the reduction in transmission from a mother living with HIV to her child.
However, antiretroviral treatment coverage among children under 15 years living with HIV remains low, with just over half receiving treatment of the 1.4 million children with HIV compared to 78% in adults.
Evidence shows that early initiation of antiretroviral therapy is lifesaving, yet coverage of these critical interventions including access to HIV testing, treatment and viral suppression remain inadequate, particularly in Africa, where >90% of children requiring HIV treatment live.
This talk will highlight progress in improving access to simplified antiretroviral regimens for children, as well as the ongoing challenges and efforts to bridge treatment access gaps and achieve global HIV treatment goals.